Ironwood Investment Counsel LLC boosted its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 125.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,800 shares of the business services provider’s stock after acquiring an additional 4,340 shares during the period. Ironwood Investment Counsel LLC’s holdings in Stericycle were worth $559,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of SRCL. JPMorgan Chase & Co. grew its stake in Stericycle by 34.6% in the 1st quarter. JPMorgan Chase & Co. now owns 16,839 shares of the business services provider’s stock valued at $1,396,000 after acquiring an additional 4,331 shares during the last quarter. OppenheimerFunds Inc. grew its stake in Stericycle by 1.2% in the 1st quarter. OppenheimerFunds Inc. now owns 5,266 shares of the business services provider’s stock valued at $436,000 after acquiring an additional 60 shares during the last quarter. Wellington Management Group LLP acquired a new stake in Stericycle in the 1st quarter valued at about $292,000. Teachers Advisors LLC grew its stake in Stericycle by 6.7% in the 1st quarter. Teachers Advisors LLC now owns 96,652 shares of the business services provider’s stock valued at $8,011,000 after acquiring an additional 6,069 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Stericycle by 55.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 377,242 shares of the business services provider’s stock valued at $31,264,000 after acquiring an additional 134,803 shares during the last quarter. 93.92% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $70.52, for a total value of $1,392,981.56. Following the transaction, the director now owns 205,576 shares of the company’s stock, valued at approximately $14,497,219.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.30% of the company’s stock.
SRCL has been the topic of a number of research reports. BidaskClub cut shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Jefferies Group LLC reissued a “buy” rating and issued a $108.00 price objective on shares of Stericycle in a research note on Thursday, July 13th. William Blair reissued an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Finally, Barclays PLC reissued an “overweight” rating and issued a $100.00 price objective on shares of Stericycle in a research note on Wednesday, August 9th. Four investment analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $81.25.
Stericycle, Inc. (NASDAQ:SRCL) traded down 2.8617% on Wednesday, reaching $68.8225. 213,397 shares of the company’s stock were exchanged. The stock’s market capitalization is $5.87 billion. The firm’s 50 day moving average is $71.33 and its 200 day moving average is $76.59. Stericycle, Inc. has a 1-year low of $68.62 and a 1-year high of $88.00.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. The firm had revenue of $917.70 million for the quarter, compared to analysts’ expectations of $902.81 million. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. Stericycle’s revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the business posted $1.18 EPS. Analysts expect that Stericycle, Inc. will post $4.59 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.com-unik.info/2017/11/01/ironwood-investment-counsel-llc-raises-position-in-stericycle-inc-srcl.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.